Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease
- PMID: 33113270
- PMCID: PMC7645850
- DOI: 10.1111/ijcp.13795
Free PMC article
Aims of the study: Patient comprehension is a critical part of meeting medical ethics standards of informed consent in study designs. The aim of the study was to determine if sufficient literature exists to require clinicians to disclose the specific risk that COVID-19 vaccines could worsen disease upon exposure to challenge or circulating virus.
Methods used to conduct the study: Published literature was reviewed to identify preclinical and clinical evidence that COVID-19 vaccines could worsen disease upon exposure to challenge or circulating virus. Clinical trial protocols for COVID-19 vaccines were reviewed to determine if risks were properly disclosed.
Results of the study: COVID-19 vaccines designed to elicit neutralising antibodies may sensitise vaccine recipients to more severe disease than if they were not vaccinated. Vaccines for SARS, MERS and RSV have never been approved, and the data generated in the development and testing of these vaccines suggest a serious mechanistic concern: that vaccines designed empirically using the traditional approach (consisting of the unmodified or minimally modified coronavirus viral spike to elicit neutralising antibodies), be they composed of protein, viral vector, DNA or RNA and irrespective of delivery method, may worsen COVID-19 disease via antibody-dependent enhancement (ADE). This risk is sufficiently obscured in clinical trial protocols and consent forms for ongoing COVID-19 vaccine trials that adequate patient comprehension of this risk is unlikely to occur, obviating truly informed consent by subjects in these trials.
Conclusions drawn from the study and clinical implications: The specific and significant COVID-19 risk of ADE should have been and should be prominently and independently disclosed to research subjects currently in vaccine trials, as well as those being recruited for the trials and future patients after vaccine approval, in order to meet the medical ethics standard of patient comprehension for informed consent.
Another warning shot over the bow that public health ‘authorities’ and the mainstream media are not alerting the public, and particularly vaccine trial participants of the very real issue of ADE.
According to our public health ‘authorities’ and bought out mainstream media, the mantra “vaccines are safe and effective” is just repeated over and over until it is believed, despite all the evidence to the contrary. People questioning this narrative are simply bullied through name-calling and below the belt hits. They are further then used to set an example to others to effectively keep the opposition at bay. Rule by fear.
Recently, Notices of Liability for COVID-19 Vaccine Harms and Deaths were served to all members of the European Parliament, and the group Stand For Health Freedom has developed an Evidence-Based Position Paper to Ensure Ethical Conduct. This latter group states that a
“theme began to stand out as a consistent concern. Safe and effective treatments for COVID-19 are inexplicably being withheld. As you read the full position paper, you will encounter many similar examples of what appears to be willful misconduct.”
Go here for a summary of the paper.
Further, even authors in a medical journal call for Ivermectin to be ‘globally and systemically deployed,” as well as 120 doctors ask JAMA to retract a flawed study downplaying the efficacy of ivermectin.
Those who dare to treat tick-borne illness appropriately have faced this persecution for 40 years – and it continues to this day.